Literature DB >> 17932508

Assessment of a computer-based treatment for older amblyopes: the Glasgow Pilot Study.

M Cleary1, A D Moody, A Buchanan, H Stewart, G N Dutton.   

Abstract

PURPOSE: There have been few viable alternatives to patching the better eye as a treatment of amblyopia for more than two centuries. The success of patching depends on compliance, which is problematic for up to 59% of children and their families.
METHODS: This pilot study trialled the interactive binocular treatment (I-BiT) system as an alternative amblyopia treatment in 12 older amblyopes (6.1-11.4 years, median 8.2), who had not complied with or responded to occlusion. Virtual reality images were projected to each eye simultaneously via a headset during eight treatment sessions of 25-min duration. Outcome measures were changes in high- (HCVA) and low-contrast log MAR acuity (LCVA) at 1 week, 4 weeks and a final follow-up (3-18 months) after the final treatment.
RESULTS: Sustained improvements in HCVA were observed in seven children (58%) and in LCVA in eight children (67%), including two for whom amblyopia was eliminated. Five children had visual acuities equivalent to 6/12 or better at least 6 months after stopping treatment, compared with one child prior to treatment. Significant improvements in HCVA occurred up to the fourth treatment; in LCVA to the seventh treatment.
CONCLUSION: Sustained improvements in visual acuity were observed for 58% of this small group of children using the I-BiT system, despite prior failure with conventional treatment. This offers hope for a potential time-saving alternative to patching, in which compliance can easily be monitored, but the results need to be validated by means of a randomised controlled trial.

Entities:  

Mesh:

Year:  2007        PMID: 17932508     DOI: 10.1038/sj.eye.6702977

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  28 in total

1.  An action video game for the treatment of amblyopia in children: A feasibility study.

Authors:  Christina Gambacorta; Mor Nahum; Indu Vedamurthy; Jessica Bayliss; Josh Jordan; Daphne Bavelier; Dennis M Levi
Journal:  Vision Res       Date:  2018-05-12       Impact factor: 1.886

Review 2.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

Review 3.  Stereopsis and amblyopia: A mini-review.

Authors:  Dennis M Levi; David C Knill; Daphne Bavelier
Journal:  Vision Res       Date:  2015-01-29       Impact factor: 1.886

4.  Interactive binocular treatment (I-BiT) for amblyopia: results of a pilot study of 3D shutter glasses system.

Authors:  N Herbison; S Cobb; R Gregson; I Ash; R Eastgate; J Purdy; T Hepburn; D MacKeith; A Foss
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

5.  One Year of Pediatric Ophthalmology and Strabismus Research in Review.

Authors:  Iris S Kassem; Marilyn T Miller; Steven M Archer
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2013 Nov-Dec

6.  Short-term effects of vision trainer rehabilitation in patients affected by anisometropic amblyopia: electrofunctional evaluation.

Authors:  Paolo Esposito Veneruso; Lucia Ziccardi; Giulia Magli; Benedetto Falsini; Adriano Magli
Journal:  Doc Ophthalmol       Date:  2014-10-08       Impact factor: 2.379

7.  Altered Balance of Receptive Field Excitation and Suppression in Visual Cortex of Amblyopic Macaque Monkeys.

Authors:  Luke E Hallum; Christopher Shooner; Romesh D Kumbhani; Jenna G Kelly; Virginia García-Marín; Najib J Majaj; J Anthony Movshon; Lynne Kiorpes
Journal:  J Neurosci       Date:  2017-07-25       Impact factor: 6.167

8.  Prentice award lecture 2011: removing the brakes on plasticity in the amblyopic brain.

Authors:  Dennis M Levi
Journal:  Optom Vis Sci       Date:  2012-06       Impact factor: 1.973

9.  Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.

Authors:  Maria Fronius; Iris Bachert; Marc Lüchtenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

10.  Emerging therapies for amblyopia.

Authors:  Michelle M Falcone; David G Hunter; Eric D Gaier
Journal:  Semin Ophthalmol       Date:  2021-03-03       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.